Ventricular Tachycardia Ablation in LVAD Patients

Launched by UNIVERSITÄTSKLINIKUM KÖLN · Sep 25, 2023

Keywords

ClinConnect Summary

The CHANNELED-Registry is a research study that aims to understand more about a heart condition called ventricular tachycardia (VT) in patients who have severe heart failure and are using a Left Ventricular Assist Device (LVAD). This study will look at how VT starts and how it can be treated with a procedure called ablation, which helps to correct the heart's rhythm. The goal is to gather important information that can improve treatment for people with this specific heart condition.

To be part of this study, participants must be adults aged 18 and older who have end-stage heart failure and have an LVAD implanted. Unfortunately, pregnant women and those undergoing VT ablation without an LVAD cannot join the study. While the study is not yet recruiting participants, those who take part can expect to contribute to valuable research that could help improve care for future patients with similar heart issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients with end-stage heart failure with an LVAD implanted undergoing VT ablation
• Exclusion Criteria:
• • Patients \<18 years, pregnant women, patients undergoing VT ablation without an LVAD